Profile

Corporate Name
Alfresa Pharma Corporation
Address
Headquarters:
2-2-9 Kokumachi, Chuo-ku, Osaka 540-8575, Japan
TEL. +81-6-6941-0300 FAX. +81-6-6947-1548
Incorporation
December 24, 1939
Capital
1 billion yen
President&CEO
Koichi Shimada
Number of Employees
1,004 employees (As of April 1, 2019)
Description of Business
Manufacture, import, export and marketing of pharmaceuticals, diagnostic products, medical devices, pharmaceutical raw materials, etc.
Banks
MUFG Bank, Ltd.

History

Mar.1920:
Nakashima Shigeru Shoten is founded as an importer and distributor of pharmaceuticals and medical devices in Manila, the Republic of Philippines.
Dec.1939:
Incorporated Nakajima Shigeru Shoten in Osaka, Japan.
Jul.1952:
Corporate name changes to Nippon Shoji Kaisha, Ltd.
Jun.1991:
Nippon Shoji Kaisha, Ltd. listed on the Second Section of the Osaka Stock Exchange.
Sep.1996:
Trading began on the First Section of the Osaka Stock Exchange.
Oct.1998:
Nippon Shoji and Showa Pharmaceuticals merge to form AZWELL Inc.
Dec.2000:
AZWELL was listed on the First Section of the Tokyo Stock Exchange.
Sep.2003:
AZWELL Inc. and Fukujin Co., Ltd. merged to found Alfresa Holdings Corporation.
Oct.2004:
Alfresa Pharma Corporation was created.
Nov.2009:
Opened Okayama Plant's Second Drug Formulation Facility.
Jun.2013:
Opened the Diagnostic Reagent Research and Development Building at the Ibaraki Research Center.
Jan.2014:
Opened Okayama Pharmaceutical Plant's Packaging Facility.
Dec.2014:
Launched Midafressa, an anticonvulsant.
jan.2015:
Renovated the Okayama Delivery Center.
Apr.2015:
Took over the Akita Plant of Daiichi Sankyo Propharma Co., Ltd., and established Alfresa Fine Chemical Corporation.
Feb.2017:
Launched AA01, a discrete clinical chemistry analyzer.

Group Companies

Alfresa Pharma is a member of the Alfresa family of companies. For more on our group philosophy, mission and vision, please visit the website of Alfresa Holdings at http://www.alfresa.com/eng/index.html